Seed Companies in Basel

RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.

Mysthera Therapeutics is a pharmaceutical company.

merakoi is a patient experience platform providing insights and solutions for the pharmaceutical, diagnostic, and medtech industries.

Fahamu is an IT firm that provides a scalable ecosystem that helps companies to become sustainability leaders.

We are on a mission to make grocery shopping waste-free.

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight.

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

CAPSERO provides solution for indoor farming in phyto pharmacy from DNA to processed harvest patent.

Bionter operates as a company with the purpose of revolutionizing analytical testing for the benefit of people's health.

Ferrosa Therapeutics is a Swiss biotechnology company founded in 2026 in Basel by Forty51 Ventures.

AERA Health is a start-up in preventive health technology

Colomba Link revolutionizes the IoT industry with the AI-powered Monidas platform, offering advanced tools for monitoring and data analysis.

Azuro is building Europe’s first user-owned portfolio of compact, designer holiday residences. Co-ownership unlocking prime European leisure

Investment, Venture Capital, Startup Accelerator

XAI Platform for Cancer Genomics Interpretation SaaS

KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases.

Axom automating visual inspection through image analysis in the healthcare industry.

OptiChroniX is a Swiss Digital Health Solutions company dedicated to improving brain health early.

TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

Renaldee AG develops the first herbal active vitamin D for chronic kidney disease.

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.

GlioCART is a University of Basel spin-out developing the first CAR-T cell therapy for glioblastoma (GBM), an aggressive brain cancer,